These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 9734549
1. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine. Meyer JH, Kennedy S, Brown GM. Am J Psychiatry; 1998 Sep; 155(9):1241-6. PubMed ID: 9734549 [Abstract] [Full Text] [Related]
2. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Am J Psychiatry; 1996 Feb; 153(2):174-82. PubMed ID: 8561196 [Abstract] [Full Text] [Related]
3. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ. Arch Gen Psychiatry; 2003 Jan; 60(1):14-22. PubMed ID: 12511168 [Abstract] [Full Text] [Related]
4. Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans. Meyer JH, Kapur S, Wilson AA, DaSilva JN, Houle S, Brown GM. Neurosci Lett; 1996 Mar 22; 207(1):25-8. PubMed ID: 8710201 [Abstract] [Full Text] [Related]
5. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. O'Keane V, Dinan TG. Am J Psychiatry; 1991 Aug 22; 148(8):1009-15. PubMed ID: 1853948 [Abstract] [Full Text] [Related]
6. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers. Mann JJ, Malone KM, Diehl DJ, Perel J, Nichols TE, Mintun MA. J Cereb Blood Flow Metab; 1996 May 22; 16(3):418-26. PubMed ID: 8621746 [Abstract] [Full Text] [Related]
7. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. Thakore JH, O'Keane V, Dinan TG. Am J Psychiatry; 1996 Nov 22; 153(11):1460-3. PubMed ID: 8890681 [Abstract] [Full Text] [Related]
8. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients. Maes M, Jacobs MP, Suy E, Minner B, Raus J. Neuropsychobiology; 1989 Nov 22; 21(4):192-6. PubMed ID: 2561010 [Abstract] [Full Text] [Related]
9. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B. Int Psychogeriatr; 1996 Nov 22; 8(1):83-102. PubMed ID: 8805090 [Abstract] [Full Text] [Related]
10. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. Meyer JH, Swinson R, Kennedy SH, Houle S, Brown GM. Psychiatry Res; 2000 May 15; 98(3):133-43. PubMed ID: 10821996 [Abstract] [Full Text] [Related]
11. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Cleare AJ, Murray RM, O'Keane V. Neuropsychopharmacology; 1996 May 15; 14(5):349-54. PubMed ID: 8703303 [Abstract] [Full Text] [Related]
12. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P, Andreason PJ, Horwitz B, Herscovitch P, Post RM. Am J Psychiatry; 1997 Feb 15; 154(2):224-30. PubMed ID: 9016272 [Abstract] [Full Text] [Related]
13. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Oquendo MA, Krunic A, Parsey RV, Milak M, Malone KM, Anderson A, van Heertum RL, John Mann J. Neuropsychopharmacology; 2005 Jun 15; 30(6):1163-72. PubMed ID: 15770239 [Abstract] [Full Text] [Related]
14. Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain. Smith DF, Poulsen PH, Ishizu K, Sakoh M, Hansen SB, Gee AD, Bender D, Gjedde A. J Neurosci Methods; 1998 Dec 31; 86(1):17-23. PubMed ID: 9894782 [Abstract] [Full Text] [Related]
15. Regional brain responses to serotonin in major depressive disorder. Anderson AD, Oquendo MA, Parsey RV, Milak MS, Campbell C, Mann JJ. J Affect Disord; 2004 Nov 01; 82(3):411-7. PubMed ID: 15555692 [Abstract] [Full Text] [Related]
16. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S. Life Sci; 1984 Mar 12; 34(11):1029-39. PubMed ID: 6700367 [Abstract] [Full Text] [Related]
17. The effects of fenfluramine on sleep and prolactin in depressed inpatients: a comparison of potential indices of brain serotonergic responsivity. Myers JE, Buysse DJ, Thase ME, Perel J, Miewald JM, Cooper TB, Kupfer DJ, Mann JJ. Biol Psychiatry; 1993 Dec 01; 34(11):753-8. PubMed ID: 8292678 [Abstract] [Full Text] [Related]
18. Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders. Kegeles LS, Malone KM, Slifstein M, Ellis SP, Xanthopoulos E, Keilp JG, Campbell C, Oquendo M, Van Heertum RL, Mann JJ. Am J Psychiatry; 2003 Jan 01; 160(1):76-82. PubMed ID: 12505804 [Abstract] [Full Text] [Related]
19. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine. Park SB, Williamson DJ, Cowen PJ. Psychol Med; 1996 Nov 01; 26(6):1191-6. PubMed ID: 8931165 [Abstract] [Full Text] [Related]
20. Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Kostić VS, Lecić D, Doder M, Marinković J, Filipović S. Biol Psychiatry; 1996 Oct 15; 40(8):769-75. PubMed ID: 8894070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]